The UK National Institute for Health and Care Excellence (NICE) has issued a Medtech Innovation Briefing (MIB) on Hemcheck’s novel point of care hemolysis detection…
Hemcheck has concluded the prepatory phase of the Bridgehead Europe program by selecting two focus markets and two local partners to support Hemcheck in the…
Hemcheck Sweden AB and Foundation for Innovative New Diagnostics (FIND) have signed an agreement regarding delivery of reader and one-time tests (v-Test). The order is…
Hemcheck Sweden AB has filed a patent application regarding a new product for the blood gas market. This is according to the current strategy to…
Hemcheck Sweden AB has been selected by a jury to participate in the EIT Health Bridgehead Europe program. The EIT, European Institute for Innovation and Technology,…
Hemcheck Sweden AB has signed a 3-month evaluation agreement, starting in June 2020, with potential continuation into a 33-month long distribution agreement with Hemakim Tibbi…
Hemcheck Sweden AB has signed a subscription agreement with SYNLAB Sverige AB regarding delivery of one reader and one-time tests (v-Test) for usage within training…
Hemcheck Sweden AB has signed a 26-month long distribution agreement with Antisel Selidis Bros SA (”ANTISEL”), one of the leading distributors of medical equipment in…
We get many questions about what the effect is on Hemcheck given the SARS-CoV-2 pandemic. On a general level it has not impacted the interest…
Recently the International congress Labquality Days was held in Helsinki with the theme “Optimizing quality and use of lab results”. Hemcheck was of course represented…
